Tech Company Financing Transactions
GlySure Funding Round
GlySure, operating out of Abingdon Oxfordshire, scored $10.9 million from Amadeus Capital, Delta Partners and Morningside Group.
Transaction Overview
Company Name
Announced On
1/10/2012
Transaction Type
Venture Equity
Amount
$10,900,000
Round
Series C
Investors
Proceeds Purpose
GlySure will use this funding to complete clinical trials to supportregulatory approval in the United States and Europe.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Abingdon Science Park The Quadrant 4-6
Abingdon Oxfordshire, OX14 3YS
UK
Abingdon Oxfordshire, OX14 3YS
UK
Phone
Website
Email Address
Overview
GlySure develops a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Moody
Chief Medical Officer
Albert Leung
Chief Technical Officer
Barry Crane
VP - Finance
Sally Mahoney
VP - Regulatory Affairs
Jan Walters
Browse more venture capital transactions:
Prev: 1/10/2012: BridgeWave Communications venture capital transaction
Next: 1/10/2012: VideoIQ venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs